FiercePharma4h
Novo Nordisk keeps manufacturing expansion spree rolling with plans for $400M quality hub in Denmark
Amid a multi-year, multibillion-dollar spending spree to scale its global manufacturing capacity, Novo Nordisk is laying down ...
FiercePharma6h
AstraZeneca's Enhertu and Akeso's bispecifics win national coverage in China as CAR-T therapies miss out again
Enhertu won its initial China nod in early 2023 as a treatment for previously treated HER2-positive breast cancer and later ...
FiercePharma8h
With AstraZeneca exec under investigation in China, company names Reic new international chief
With AstraZeneca’s former international chief, Leon Wang, under investigation in China, the company has promoted an AZ ...
FiercePharma9h
Sumitomo brings together Gemtesa 'Go-Getters' to discuss overactive bladder symptoms
The latest iteration of the campaign builds on Sumitomo’s work to expand the Go-Getter program. The “Time to Go” website now ...
FiercePharma10h
Novavax scores $200M as it hands over keys to Czech production plant—along with 300 employees—to Novo Nordisk
With the purchase of a plant in the Czech Republic, Novo Nordisk is saying “jak se máš” to hundreds of new employees—and ...
FiercePharma12h
Eli Lilly's Zepbound defeats Novo Nordisk's Wegovy in head-to-head weight loss trial
Over the last two-plus years, as Eli Lilly and Novo Nordisk have battled for their share of the massive weight loss market ...
FiercePharma13h
New BeiGene campaign encourages biomarker testing before treatment for CLL patients
How well a certain treatment for chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) works can vary ...